Troglitazone and small low-density lipoprotein in type 2 diabetes

被引:22
|
作者
Hirano, T [1 ]
Yoshino, G
Kazumi, T
机构
[1] Showa Univ, Sch Med, Tokyo 142, Japan
[2] Toho Univ, Sch Med, Tokyo, Japan
[3] Ilyogo Rehabil Ctr Hosp, Tokyo, Japan
关键词
D O I
10.7326/0003-4819-129-2-199807150-00030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:162 / 163
页数:2
相关论文
共 50 条
  • [1] Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
    Juhi, Ayesha
    Jha, Kamlesh
    Mondal, Himel
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [2] Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes
    Esteghamati, Alireza
    Asnafi, Solmaz
    Eslamian, Mohammad
    Noshad, Sina
    Nakhjavani, Manouchehr
    [J]. ENDOCRINE RESEARCH, 2015, 40 (01) : 14 - 19
  • [3] Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients
    Inukai, T
    Yamamoto, R
    Suetsugu, M
    Matsumoto, S
    Wakabayashi, S
    Inukai, Y
    Matsutomo, R
    Takebayashi, K
    Aso, Y
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2005, 19 (05) : 269 - 275
  • [4] Association between measured or calculated small dense low-density lipoprotein cholesterol and oxidized low-density lipoprotein in subjects with or without type 2 diabetes mellitus
    Kim, Hyun-Ki
    Hong, Jinyoung
    Ahn, Sunyoung
    Lee, Woochang
    Chun, Sail
    Min, Won-Ki
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [5] Targeting Low-Density Lipoprotein AND Dysmetabolism in Type 2 Diabetes Mellitus
    Goldberg, Ronald
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (03) : 477 - 478
  • [6] Free fatty acids and low-density lipoprotein oxidation in type 2 diabetes
    C. Phillips
    D. Owens
    P. Collins
    G. H. Tomkin
    [J]. Irish Journal of Medical Science, 2002, 171 (Suppl 5) : 14 - 15
  • [7] Autoantibodies to oxidized low-density lipoprotein in patients with Type 2 diabetes mellitus
    Hsu, RM
    Devaraj, S
    Jialal, I
    [J]. CLINICA CHIMICA ACTA, 2002, 317 (1-2) : 145 - 150
  • [8] Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study
    Janghorbani, Mohsen
    Soltanian, Nouralddin
    Amini, Masoud
    Aminorroaya, Ashraf
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (05) : 715 - 719
  • [9] In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes
    Jenkins, AJ
    Thorpe, SR
    Alderson, NL
    Hermayer, KL
    Lyons, TJ
    King, LP
    Chassereau, CN
    Klein, RL
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (08): : 969 - 976
  • [10] Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl
    Cromwell, William C.
    Otvos, James D.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (12): : 1599 - 1602